Mainolfi Nello sold KYMR
July 7, 2026 · Form 4 insider transaction
Mainolfi Nello sold 4,441 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
4,441
Price
$0.00
Total value
N/A
InsiderMainolfi Nello
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeM: Option exercise
Transaction dateJuly 7, 2026
Filing dateJuly 7, 2026
Shares owned after14,284
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 24, 2026 adopted by the reporting person.; The shares underlying this stock option are fully vested and exercisable.